EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Doxorubicin-Incorporated Nanoparticles Composed of Ce6-Conjugated Hyaluronic Acid-b-poly(ethylene glycol) Copolymer for Overcoming Doxorubicin Resistance of Breast Cancer Cells

Tae Hyeon Kim iD, Kyung-Jin Oh iD, Myeong Yoo Park, Ilkeun Kong iD, Jaewon Jo, Young-Ju Lee, Hyo-Young Lee, Doug-Hoon Kim, Jinsu Park, Jae-Woon Nah, Young-Il Jeong iD

International Journal of Molecular Sciences · 04.08.2026 · 27 (15) · 6993

DOI: 10.3390/ijms27156993 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.08.2026. Verfasst von Tae Hyeon Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Animal Science, Gyeongsang National University, Jinju 52828, Republic of Korea. Hauptthemen laut MEDLINE: Doxorubicin, Hyaluronic Acid, Polyethylene Glycols, Drug Resistance, Neoplasm. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chonnam National University Hospital, Chonnam National University Hospital Biomedical Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress in the tumor microenvironment, which is its own intrinsic property, is frequently utilized to deal with the drug-targeting issue in the nanoparticle drug delivery system. For this purpose, reactive oxygen species (ROS)-sensitive nanoparticles encapsulating doxorubicin (DOX) and chlorin e6 (Ce6) were synthesized for treatment of MDA-MB-231 breast cancer cells. Hyaluronic acid (HA) with a reductive end was conjugated with methoxy poly(ethylene glycol) (PEG) using thioketal diamine (ThdNH2) linkage (HA-b-PEG copolymer). Then, Ce6 were conjugated to the carboxylic acid group of HA via ThdNH2 (HA(Ce6)-b-PEG copolymer). DOX was physically incorporated to make DOX-incorporated HA(Ce6)-b-PEG copolymer nanoparticles (DOX-NP). HA(Ce6)-b-PEG copolymer nanoparticles (empty NP) and DOX-NP have a tiny particle size, less than 200 nm, with spherical morphology. They were responsively disintegrated according to the hydrogen peroxide (H2O2) concentration, then the release rate of Ce6 or DOX was accelerated, indicating that empty NP and DOX-NP have ROS sensitivity. DOX-resistant MDA-MB-231 cells were prepared by continuous treatment of DOX for three months. DOX-NP were efficiently internalized into the cells while intra-cellular delivery of DOX itself was inhibited. DOX-NP has higher anticancer activity against DOX-resistant MDA-MB-231 cells than that of DOX itself since cells were resistant to DOX itself. Under light irradiation, DOX-NP significantly decreased the viability of DOX-resistant MDA-MB-231 cells while DOX itself did not properly affect cell viability. Empty NP also efficiently inhibited cell viability rather than that of Ce6 itself while both of them did not affect the cell viability in the absence of light irradiation. Furthermore, empty NP showed higher ROS generation than that of Ce6 itself. DOX-NP more efficiently induced apoptosis/necrosis than DOX itself. In DOX-resistant MDA-MB-231 cell-bearing mice, DOX-NP was efficiently delivered to tumor tissue. DOX-NP greatly inhibited the growth of tumors under light irradiation, more than that of DOX itself or empty NP. In conclusion, DOX-NP showed promising antitumor activity against DOX-resistant MDA-MB-231 cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinHyaluronic AcidPolyethylene GlycolsDrug Resistance, NeoplasmBreast NeoplasmsNanoparticlesPorphyrinsHumansFemaleAnimalsChlorophyllidesMiceReactive Oxygen SpeciesMDA-MB-231 CellsCell Line, TumorAntibiotics, AntineoplasticDrug Carriers

Stichwörter der Autor:innen

chemotherapydrug-resistant cancernanoparticlesphotodynamic therapyreactive oxygen speciestumor targeting

Substanzen

DoxorubicinHyaluronic AcidPolyethylene GlycolsChlorophyllidesphytochlorinPorphyrinsReactive Oxygen SpeciesAntibiotics, AntineoplasticDrug Carriers

Autor:innen und Institutionen

  • Division of Animal Science, Gyeongsang National University, Jinju 52828, Republic of Korea.
  • Department of Urology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju 61469, Republic of Korea.
  • Gwangju Center, Korea Basic Science Institute, Gwangju 61186, Republic of Korea.
  • Department of Radiological Science, Dong-Eui University, Pusan 47340, Republic of Korea.
  • Department of Optometry, Masan University, Changwon 51217, Republic of Korea.
  • The Korean Association for the Industrial Technology Security, Seoul 06732, Republic of Korea.

ORCID-Profile: Tae Hyeon Kim, Kyung-Jin Oh, Ilkeun Kong, Young-Il Jeong

Förderung

  • Chonnam National University Hospital
  • Chonnam National University Hospital Biomedical Research Institute

Zitieren

APA

Kim, T. H., Oh, K. J., Park, M. Y., Kong, I., Jo, J., Lee, Y. J., Lee, H. Y., Kim, D. H., Park, J., Nah, J. W., & Jeong, Y. I. (2026). Doxorubicin-Incorporated Nanoparticles Composed of Ce6-Conjugated Hyaluronic Acid-b-poly(ethylene glycol) Copolymer for Overcoming Doxorubicin Resistance of Breast Cancer Cells. International Journal of Molecular Sciences, 27(15), 6993. https://doi.org/10.3390/ijms27156993

Vancouver

Kim TH, Oh KJ, Park MY, Kong I, Jo J, Lee YJ, et al. Doxorubicin-Incorporated Nanoparticles Composed of Ce6-Conjugated Hyaluronic Acid-b-poly(ethylene glycol) Copolymer for Overcoming Doxorubicin Resistance of Breast Cancer Cells. International Journal of Molecular Sciences. 2026;27(15):6993. doi:10.3390/ijms27156993

BibTeX
@article{Kim2026,
  author = {Kim, Tae Hyeon and Oh, Kyung-Jin and Park, Myeong Yoo and Kong, Ilkeun and Jo, Jaewon and Lee, Young-Ju and Lee, Hyo-Young and Kim, Doug-Hoon and Park, Jinsu and Nah, Jae-Woon and Jeong, Young-Il},
  title = {Doxorubicin-Incorporated Nanoparticles Composed of Ce6-Conjugated Hyaluronic Acid-b-poly(ethylene glycol) Copolymer for Overcoming Doxorubicin Resistance of Breast Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {6993},
  doi = {10.3390/ijms27156993}
}
Kostenlos starten →